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  19 
Abstract 20 
 21 
Secondary transporters undergo structural rearrangements to catalyze substrate 22 
translocation across the cell membrane – yet how such conformational changes 23 
happen within a lipid environment remains poorly understood. Here, we combine 24 
hydrogen-deuterium exchange mass spectrometry (HDX-MS) with molecular 25 
dynamics (MD) simulations to understand how lipids regulate the conformational 26 
dynamics of secondary transporters at the molecular level. Using the homologous 27 
transporters XylE, LacY and GlpT from Escherichia coli as model systems, we 28 
discover that conserved networks of charged residues act as molecular switches that 29 
drive the conformational transition between different states. We reveal that these 30 
molecular switches are regulated by interactions with surrounding phospholipids and 31 
show that phosphatidylethanolamine interferes with the formation of the conserved 32 
networks and favors an inward-facing state. Overall, this work provides insights into 33 
the importance of lipids in shaping the conformational landscape of an important 34 
class of transporters. 35 
 36 
 37 
  38 
Introduction 39 
Secondary membrane transporters play crucial roles in maintaining adequate 40 
conditions for life by catalyzing uphill transport of biomolecules through the biological 41 
membrane, using energy stored in transmembrane ions gradients. The majority of 42 
known secondary transporters are grouped in the Major Facilitator Superfamily 43 
(MFS), which represents the largest evolutionary related family of transporters1. This 44 
family comprises many disease-related human transporters2. For example, the GLUT 45 
sugar transporters are involved in cancer metabolism3 and malfunction of the 46 
glucose-6-phosphate transporter G6PT is associated with glycogen storage 47 
disease4. Despite functional diversity, the architecture of MFS transporters is 48 
remarkably well conserved, which suggests that key mechanistic features are 49 
maintained within the family5. These proteins are dynamic entities, coupling opening 50 
on one side of the membrane with closing on the opposite side to provide alternate 51 
access to a central substrate binding site6. The typical structural fold of the 52 
transporters contains 12 transmembrane helices (TMs) arranged in two pseudo-53 
symmetrical six-helical bundles, the N- and C-lobes, rocking back and forth to allow 54 
substrate translocation7. Recently, high-resolution crystal structures have provided 55 
invaluable molecular insights into the alternating-access mechanism of MFS 56 
transporters by unveiling various conformational states ranging from outward-facing 57 
(OF) to inward-facing (IF)8,9,10 .  58 
Despite the wealth of information offered by atomic-resolution structures, they 59 
can only give very limited information on the important role that the lipid environment 60 
plays in the molecular mechanism of transport. Recent studies have shown that the 61 
biophysical properties of the membrane and lipid-protein interactions play a crucial 62 
role in modulating the function11,12, structure13, stability14-16, oligomeric state17,18 and 63 
conformational dynamics19,20 of transporters. Furthermore, the static structural 64 
snapshots fail to report the dynamic interconversion between different conformers, 65 
which underpins the transport cycle. Thus, a method that interrogates the 66 
conformational dynamics within a lipid environment is required to gain fundamental 67 
insights into the mechanism of membrane transport.  68 
Recently, hydrogen-deuterium exchange mass spectrometry (HDX-MS) has 69 
emerged as a powerful technique to monitor the conformational dynamics21 of 70 
membrane proteins in various membrane mimics such as detergent micelles 22,23, 71 
bicelles24, native lipid nanodiscs (SMALPs) 25 and artificial lipid nanodiscs26 as well 72 
as liposomes27. HDX reports the exchange of labile amide hydrogens on the protein 73 
backbone in the presence of bulk deuterium28. When coupled to enzymatic digestion 74 
and followed by liquid-chromatography mass spectrometry (LC-MS) analysis of the 75 
resulting peptides, this technique allows deuterium uptake to be mapped at a peptide 76 
level of resolution. The most insightful information stems from differential 77 
measurements of relative deuterium uptake, obtained by comparing two different 78 
protein states. Significant differences in deuterium uptake between two distinct 79 
conditions (e.g. mutant and wild-type protein) are mapped onto a 3D protein 80 
structure of allowing visualization of the changes in structural dynamics29. A major 81 
advantage of this methodology is that it enables conformational characterization of 82 
proteins in solution without requiring covalent modification of the target, 83 
circumventing labelling issues that arise in many biophysical studies. A recent study 84 
on the neurotransmitter LeuT combined HDX-MS in nanodiscs with molecular 85 
dynamics (MD) simulations to identify dynamic changes in key structural elements 86 
demonstrating the successful application of this method to membrane proteins30. 87 
However, no study yet has used HDX-MS to study the role that lipids have on the 88 
conformational dynamics of transporters. 89 
Here, we describe the systematic investigation of the conformational 90 
landscape of three well-characterized transporters: lactose permease LacY, xylose 91 
transporter XylE, both symporters, and glycerol-3-phosphate antiporter GlpT, all from 92 
Escherichia coli. We chose these three targets due to the availability of their crystal 93 
structures9,31,32 and the potential insights our results could provide into the 94 
mechanism of their mammalian counterparts. GlpT and XylE are bacterial homologs 95 
of the mammalian transporters G6PT and GLUT1 respectively, and LacY is selected 96 
as it represents the most extensively characterized secondary transporter to date33. 97 
Our HDX-MS experiments in detergent micelles identify cytoplasmic charge 98 
networks of amino acids that act as molecular switches controlling the 99 
conformational equilibrium, through a mechanism conserved across all three 100 
transporters. Combining MD simulations and HDX-MS experiments of XylE and 101 
LacY embedded in nanodiscs of different lipid compositions, we show that 102 
phosphatidylethanolamine (PE) modulates the conformational equilibrium between 103 
OF and IF states through interactions with the identified networks of charged 104 
residues. Overall, this work suggests a model of secondary transport in which 105 
interactions between lipids and protein at conserved charge networks control the 106 
conformational equilibrium.  107 
  108 
Results 109 
HDX-MS reports on conformational changes of transporters  110 
An important prerequisite to our mechanistic investigation was to ensure that 111 
HDX-MS can consistently report on changes in the conformational equilibrium of 112 
different MFS transporters. To validate our methodology, we shifted the 113 
conformational equilibrium towards outward-facing (OF) conformers by introducing a 114 
bulky tryptophan in place of a conserved glycine on the extracellular side between 115 
helix 2 and 11 (Fig.1a and Supplementary Fig.1). This approach was successfully 116 
utilized in the first high-resolution structure determination of LacY in an OF 117 
conformation34. We measured the difference in relative deuterium uptake (∆HDX) 118 
between the mutants LacY G46W, XylE G58W, and GlpT G66W and the respective 119 
wild-type (WT) transporter in detergent micelles (Fig. 1b and Supplementary Figs. 120 
12, 13). Only the peptides displaying a significant ∆HDX (99% confidence interval) 121 
were kept for downstream analysis (see Methods). By mapping the ∆HDX values on 122 
the crystal structure of each transporter, we observe that peptides from the 123 
intracellular and the extracellular sides display opposite deuterium uptake profiles. 124 
Regions on the extracellular side of all three mutants take up more deuterium 125 
compared to the wild-type, whereas regions on the intracellular side are 126 
comparatively protected from deuterium exchange. This pattern is consistent with a 127 
shift in the conformational equilibrium towards an OF-state and shows that HDX-MS 128 
can report on changes in the conformational equilibrium of MFS transporters within 129 
the framework of the alternating-access mechanism. 130 
Conserved charge networks control the conformational shift 131 
We then set out to identify molecular switches regulating the conformational 132 
transition between IF and OF conformations. The most conserved sequence motif of 133 
the MFS family, originally termed motif A35, is the central point of charge-relay 134 
networks present on the intracellular side (Fig. 2a and Supplementary Figs. 2, 3). 135 
Previous structural and biophysical studies have suggested that these charge 136 
networks play a role in stabilizing the OF conformation36-38. To understand how this 137 
motif regulates transporter dynamics we disrupted the charge-relay networks while 138 
minimizing steric perturbation by introducing conservative mutations of its acidic 139 
residues. We produced the following mutants: D68N and E139Q for LacY, D337N, 140 
E397Q and E153Q for XylE and D314N and E374Q for GlpT and subjected them to 141 
differential HDX-MS measurements using the respective WT transporter as the 142 
control. Interestingly, our ∆HDX maps show that all mutations trigger increased 143 
deuterium uptake on the intracellular side coupled to decreased uptake on the 144 
extracellular side (Fig. 2b, c, d). These patterns indicate that the IF conformation is 145 
favored in the presence of these mutations. These results strongly suggest that the 146 
conserved networks on the intracellular side play a role as conformational molecular 147 
switches. 148 
Another characteristic feature of secondary MFS transporters is the presence 149 
of conserved charged residues within the transmembrane region (Supplementary 150 
Fig. 3). Previous functional characterization of the residues D27 for XylE9, E325 for 151 
LacY33 and E299 for GlpT39 showed that they are essential for transport but not for 152 
substrate binding, which suggests that they are likely to play a role in structural 153 
rearrangements enabling alternating-access. We mutated each carboxylate residue 154 
into its amine equivalent (i.e D27N for XylE, E325Q for LacY and E299Q for GlpT) 155 
and monitored the changes in deuterium uptake compared to the respective WT 156 
transporter using differential HDX-MS. In contrast to our previous results, the three 157 
transporters displayed different conformational responses (Supplementary Fig. 4). 158 
The ∆HDX map of GlpT suggests that the perturbation of the salt-bridge between 159 
E299 and K46 caused a shift towards OF conformation (Supplementary Fig. 4a). 160 
∆HDX maps of XylE and LacY indicate a closing of the extracellular side which is not 161 
coupled to an opening on the intracellular side (Supplementary Fig. 4b, c). Such 162 
independent rearrangements at both sides of the transporter has already been 163 
suggested for LacY40 and may indicate a mechanism shared by other MFS 164 
transporters.  165 
Together, these results underline the complexity of the molecular mechanisms 166 
involved in the conformational changes over the course of the transport cycle. The 167 
disruption of the extracellular salt-bridges causes a variety of structural responses, 168 
which may reflect the differences in energetics between the antiporter GlpT and the 169 
symporters XylE and LacY. In contrast, the disruption of the cytoplasmic charge-170 
relay networks consistently opens the intracellular side, independent of the 171 
transporter type or specific function. 172 
Lipids modulate the conformational equilibrium 173 
Having established that disruption of conserved cytoplasmic charge networks 174 
triggers a conformational transition towards the IF state, we investigated the role of 175 
specific lipid-protein interactions in regulating this transition. A previous study on the 176 
MFS multidrug transporter LmrP suggested that a direct interaction between 177 
phosphatidylethanolamine and a conserved cytoplasmic network facilitated the 178 
conformational transition between IF and OF states19. 179 
Building upon this knowledge, we characterized the conformational shifts of 180 
XylE in nanoscale soluble phospholipid bilayers (nanodiscs) composed of two 181 
different lipid environments: a) phosphatidylethanolamine (PE), phosphatidylglycerol 182 
(PG) and tetraoleyl cardiolipin (CL), or b) phosphatidylcholine (PC), PG and CL, both 183 
in a 7:2:1 ratio. The first resembles the native lipid composition of the E. coli 184 
membrane41 and the second contains the non-native PC lipid and is used as a 185 
control. We utilized 1,2-dioleoyl-sn-glycerol lipids in each nanodisc because they are 186 
among the most abundant lipid types in bacterial membranes and they all have 187 
transition temperatures below 0 °C, allowing for efficient reconstitution. Following 188 
careful optimization of the HDX workflow (Fig. 3a and Methods), we obtained a high 189 
level of sequence coverage in nanodiscs ranging from 76% up to 85% 190 
(Supplementary Fig. 5). To demonstrate that the protein is functional when inserted 191 
in the nanodiscs, we mapped ∆HDX in the absence and presence of the substrate 192 
xylose, and repeated the experiment in detergent micelles. In both cases, the 193 
presence of substrate shifted the conformational equilibrium toward the OF state 194 
(Supplementary Fig. 6). The associated conformational changes confirmed xylose 195 
binding and offered a good indication that the protein is folded and reconstituted. As 196 
additional controls, we used thin layer chromatography to ensure that the nanodisc 197 
reconstitution procedure does not select a specific lipid species (Supplementary 198 
Fig.7) and native mass spectrometry to assess the absence of detergent trace in the 199 
final nanodiscs samples (Supplementary Fig. 8).  200 
Interestingly, we observe a decrease in deuterium uptake on the extracellular 201 
side in the PE nanodiscs compared to the PC nanodiscs. This is coupled to an 202 
increase in deuterium uptake on the intracellular side (Fig. 3b). Specifically, the 203 
loops between TM1 and TM2, TM3 and TM4, and TM11 and TM12 on the 204 
extracellular side and the loop between TM2 and TM3 on the intracellular side 205 
displayed significant ∆HDX between the two lipid environments (Fig.3 c-f). This 206 
∆HDX profile suggests that the presence of PE favors the opening on the 207 
intracellular side and closing on the extracellular side, promoting a shift towards an 208 
IF conformation. To test the generality of such result, we carried out an identical 209 
experiment using LacY. Similar to XylE, we observed an increase in deuterium 210 
uptake on the intracellular side, coupled to a slight decrease on the extracellular side 211 
in the PE nanodiscs compared to the PC nanodiscs (Supplementary Fig. 9). These 212 
results indicate that the composition of the phospholipid headgroup significantly 213 
affects the conformational equilibrium of both secondary transporters. 214 
MD simulations reveal direct lipid-protein interactions  215 
Having established that a change in the lipid environment modulates the 216 
conformational dynamics of the transporters XylE and LacY, we set out to identify 217 
the origin of such conformational regulation at a molecular level. We carried out all-218 
atom MD simulations of each transporter embedded in lipid bilayers of identical 219 
composition to the nanodiscs used in our HDX-MS experiments. We performed two 220 
sets of simulations of 500ns each (Methods), starting from the crystal structure of 221 
XylE and LacY resolved in the inward-open conformation (PDB 4JA4 and 2CFQ 222 
respectively) (Fig. 4a and Supplementary Fig. 10).  223 
Interestingly, the MD simulations predicted direct interactions between the 224 
lipid bilayer and the cytoplasmic networks identified as molecular switches (Fig. 4b, 225 
c). The simulations of XylE in PE:PG:CL bilayers consistently showed PE interacting 226 
with the networks, either by direct interactions of the PE headgroup with the acidic 227 
residues E153 (Fig. 4b,c and Supplementary Movie 1) and D337 (Fig.4c) or by 228 
steric interferences with the whole networks (Fig.4c). In contrast, no specific or non-229 
specific interactions between the protein and PC were observed. (Fig.4c). Similar 230 
results were obtained for LacY where direct interactions between PE and the acidic 231 
residue E139 were observed in PE but not in PC bilayers (Supplementary Fig. 10 232 
and Supplementary Movie 2). Furthermore, the simulations of XylE in PC:PG:CL 233 
bilayers predicted a closing of the intracellular side of the protein. This 234 
conformational change is initiated by the inward motion of TM2 and TM3 towards 235 
TM10 and TM11 (Fig. 5a). Such a conformational change was not observed in PE-236 
based lipid bilayers. Specifically, in the last 200 ns of both simulations we observed 237 
that the intracellular gates converge to a significantly shorter 9 Å distance in the 238 
presence of PC but stay open at distance of ~ 13 Å in the presence of PE (Fig. 239 
5b,c). This is in line with our HDX-MS observations showing that PE lipids shift the 240 
conformational equilibrium towards an IF state. These observations suggest that the 241 
lipid-induced conformational shift results from direct interaction of the conserved 242 
cytoplasmic networks with PE. 243 
We speculated that such an effect would be abolished or decreased if the 244 
charge networks are already perturbed or disrupted. To test this hypothesis, we 245 
reconstituted the XylE mutants E153Q (disruption of network 1) and E397Q 246 
(disruption of network 2) into nanodiscs containing either PE or PC and subjected 247 
them to differential HDX-MS. The mutant XylE E153Q did not show any significant 248 
∆HDX between the two lipid environments (Fig. 6a), confirming that the perturbation 249 
of network 1 nullifies the PE induced conformational shift. The mutant XylE E397Q 250 
displayed no significant ∆HDX, with the only exception of the TM1-TM2 extracellular 251 
loop, more exposed in PC-based nanodiscs (Fig. 6b). These experiments strongly 252 
suggest that PE favors inward opening by perturbing the cytoplasmic charge 253 
networks we evidenced. To further confirm that the conformational changes were 254 
caused by direct lipid-protein-interaction and not differences in the curvature 255 
properties of PE and PC, we performed differential HDX-MS measurements of XylE 256 
in nanodiscs composed of DOPE with one methyl group on the amine headgroup 257 
(DOPE(Me)1:DOPG:CL) and in DOPC:DOPG:CL lipid nanodiscs. According to 258 
previous work42, the curvature properties of DOPE decreases linearly with the 259 
addition of each methyl group on the amine. Hence, the curvature properties of the 260 
DOPE(Me)1 nanodiscs should be comparatively closer to the DOPE than the DOPC 261 
nanodiscs. If the observed shift in the conformational equilibrium is caused by a 262 
difference in curvature properties, such shift should still be observed. However, our 263 
HDX-MS experiments show that there is no significant difference in uptake between 264 
the DOPC and DOPE(Me)1 nanodiscs, which indicates that their conformational 265 
landscape is identical (Supplementary Fig.11). Overall, the combination of ∆HDX 266 
experiments and MD simulations in two lipid environments shows that the 267 
conformational dynamics of a secondary transporter are controlled by specific lipid-268 
protein interactions.  269 
 270 
  271 
Discussion 272 
In this work, we identify conformational roles for the most conserved motif of 273 
the MFS superfamily, occurring through specific lipid-protein interactions. 274 
Furthermore, we show that ∆HDX measurements in nanodiscs of different lipid 275 
compositions can be used to understand how specific lipid environments fine-tune 276 
the conformational dynamics of transporters. 277 
A number of independent studies have previously proposed that motif A 278 
integrity is crucial to stabilize the OF conformation of MFS transporters through 279 
conserved charge-relay networks37,38,43. We demonstrate that the disruption of these 280 
cytoplasmic charge networks by mutagenesis or the presence of specific lipids 281 
systematically causes a shift towards the IF state (Fig. 2b, c, d), a finding consonant 282 
with the proposed structural role of the A-like motifs. The conservation of A-like 283 
motifs in MFS transporters from a variety of organisms suggests that the disruption-284 
reformation of these networks is likely to be a conserved mechanism driving 285 
conformational transition44.  286 
A major finding of this study is the identification of direct lipid-protein 287 
interactions between the charge-relay networks of MFS transporters and the amine 288 
headgroup of the PE phospholipid. The synergistic power of MD and HDX-MS 289 
revealed a key role for this interaction in the conformational regulation of XylE and 290 
LacY. Indeed, while differential HDX-MS experiments indicated a shift towards the IF 291 
state in PE-based nanodiscs, MD simulations showed how the PE headgroup 292 
promotes this conformation by preventing the contacts required for the 293 
conformational transition. PE interacts with the intracellular ends of the so-called 294 
gating-helices (TM5-TM8 and TM2-TM11) and hinders the formation of an N- and C-295 
lobe interface (Fig. 4c). Even more striking is the motion of the PE phospholipid 296 
inside the transporter, interacting directly with residues E153, R84 and D337 of XylE 297 
(Fig. 4b,c and Supplementary Movie 1). Similar direct interactions between PE and 298 
residue E139 of LacY (Supplementary Fig. 10 and Supplementary Movie 2) were 299 
also observed, in line with a previous computational study of LacY in different lipid 300 
environments45.  301 
These interactions shed light on the central role of these conserved charge-302 
relay networks. Our study suggests that such networks are crucial not only in the 303 
stabilization of the OF state, but of the IF state as well. In this scenario, direct 304 
interactions between the PE headgroup and residues forming the networks stabilize 305 
the IF state. This hypothesis agrees with the findings of a previous study on the MFS 306 
transporter LmrP which used DEER spectroscopy to show that the conformational 307 
equilibrium was shifted towards the IF state in DOPE-based nanodiscs19. 308 
Furthermore, a number of studies have shown significant functional differences for 309 
the transporters LacY46,47, MelB48 from E. coli, LmrP49 from Lactoccocus lactis, and 310 
the branched-chain amino acid transport system of Streptococcus cremoris50 311 
reconstituted in PE- and PC-based liposomes. These studies all indicated that the 312 
presence of PE in the lipid bilayer improves transport efficacy. We speculate that 313 
these functional differences arise partly from a shift of the conformational equilibrium 314 
caused by the lack of PE. The absence of direct interactions between PE and the 315 
transporter would give rise to a conformational imbalance limiting transport turnover. 316 
However, long-range effects such as lateral pressure and membrane curvature are 317 
also present in liposomes and in vivo, and likely to affect function as well. 318 
Our findings allow us to reconsider the current alternating-access model for 319 
MFS transporters. A comprehensive description of a transport cycle rests on the 320 
ability to identify specific pathways along a free energy landscape that allow 321 
interconversion between inward- and outward-facing conformations. Alongside other 322 
studies, this work demonstrates that the depiction of such landscapes must account 323 
for the role of the surrounding lipid environment. We propose an updated transport 324 
mechanism that includes direct protein-lipid interactions, exemplified by the proton-325 
coupled symporter XylE and its interaction with PE (Fig. 7). Substrate (Fig.7 – i) and 326 
proton (Fig.7 – ii) binding from the periplasm to the OF conformation initiates the 327 
conformational transition towards an occluded state (Fig. 7 – iii). In the case of the 328 
symporter XylE, our work and other studies51 suggest that proton binding at residue 329 
27 will trigger the extracellular closing. The proton would then travel from residue 27 330 
to one of the conserved acidic residues of the cytoplasmic charge networks and 331 
disrupt the stabilizing charge networks (Fig. 7 – iv). The disruption of these networks 332 
will trigger the opening of the protein on the intracellular side. The exposure to the 333 
slightly basic intracellular pH will lead to spontaneous deprotonation and intracellular 334 
proton release. Direct interactions between PE lipids and the charge networks will 335 
stabilize IF conformation, thus facilitating substrate release into the cytosol (Fig.7 – 336 
v). The apo transporter can transition back to an OF conformation and start a new 337 
transport cycle (Fig.7 – vi). In secondary active transport, the substrate release and 338 
subsequent conformational switch of the transporter after a complete cycle is the 339 
rate-limiting step52,53. Our model suggests that a balance between formation of a 340 
charge network on the intracellular side (which favors the OF state) and direct 341 
interactions of the charged residues with PE (which favor the IF state) defines the 342 
energy barrier of this conformational transition, thus setting up the optimal transport 343 
rate. 344 
It is interesting to note that the residues forming the cytoplasmic networks 345 
observed on XylE are also present on the mammalian homologs GLUTs1-510, which 346 
function as uniporters. Comparison of the crystal structures of GLUT354 and 347 
GLUT555 (captured in outward-open and outward-occluded conformations 348 
respectively) with the outward-occluded conformation of XylE indicate that they 349 
share an identical structural arrangement (Supplementary Fig. 2). Mutations in the 350 
corresponding charge networks of GLUT1 have been associated with Glucose 351 
Deficiency Syndrome56. These findings underline the importance of these networks 352 
even in transporters that are not proton-coupled and support our hypothesis that 353 
other molecular mechanisms, such as direct lipid-protein interactions, play a role in 354 
the conformational regulation underpinning function.  355 
 However, the conservation of these networks in transporters from different 356 
species does not coincide with conservation of the lipid bilayer composition. While 357 
PE lipids are the main component of the inner bacterial membrane of E.coli, their 358 
distribution is very diverse in other forms of life. In mammals, the chemical diversity 359 
of membrane lipids is much more complex and PE-based phospholipids are a minor 360 
species in most mammalian membranes57. It is possible that other types of protein-361 
lipid interactions play a similar role as conformational regulators. For example, a 362 
recent study has shown the requirement of anionic phospholipids for the activity of 363 
GLUT 3 and 4 and demonstrated that this functional regulation happens through 364 
direct lipid-protein interactions58. Another secondary transporter, the dopamine 365 
neurotransmitter DAT is sensitive to the presence of the lipid PIP2 and MD 366 
simulations suggest that this functional regulation occurs through direct lipid-protein 367 
interactions20. We speculate that conformational regulation by specific lipid-protein 368 
interactions is a widespread mechanism followed by many other transporters.  369 
Our approach that combines MD simulations with HDX-MS in tuneable 370 
nanodiscs provides an important new window into the relationship between structural 371 
and sequence conservation of transporters and membrane diversity across different 372 
animal kingdoms. This work widens our understanding of the molecular mechanisms 373 
governing transporter dynamics and provides a framework to study similar systems, 374 
such as the clinically relevant SLC transporters59. 375 
376 
Methods 377 
Materials 378 
Lipids were purchased from Avanti Polar Lipids Inc and detergents from 379 
Anatrace. Unless otherwise stated, all other chemicals were purchased from Sigma 380 
Aldrich. 381 
Design and construction of the mutants 382 
The mutations were introduced in the C-terminally histidine-tagged proteins by 383 
site-directed mutagenesis using a QuikChange Lightning kit (Stratagene).Primers 384 
are listed in Supplementary Table 1. After transformation, plasmid DNA was 385 
extracted using Qiaprep miniprep kit and verified by sequencing (Genewiz UK). The 386 
plasmid containing the desired mutation was transformed in E.coli BL21-AI cells 387 
(Invitrogen) for overexpression.  388 
Protein expression and purification 389 
LacY, GlpT and XylE were overexpressed in E. coli BL21-AI (Invitrogen) and 390 
purified using the same protocol as previously described 14 with the following 391 
modifications. Briefly, BL21-AI cells were transformed with the lacy, xyle or glpt gene 392 
– with or without the chosen mutations - cloned in the kanamycin-resistant pET28 393 
plasmid (Novagen) with a C-terminal 10-histidine tag, grown in LB media at 37C 250 394 
rpm to an OD600 of 0.8. Expression was induced with 1ௗmM IPTG and 0.1% (w/v) 395 
arabinose and growth continued until saturation. The cells were harvested, passed 396 
through a microfluidiser (Constant Systems) and the membranes isolated by 397 
centrifugation for 30ௗmins at 100,000 × g. Membrane proteins were solubilised for 2 398 
hours in 50ௗmM sodium phosphate, 100ௗmM NaCl, 10% (v/v) glycerol, 20ௗmM 399 
imidazole, 2ௗmM B-mercaptoethanol, pH 7.4 with 2% (w/v) ȕ-DDM (Anatrace). In the 400 
case of GlpT, sodium phosphate was replaced in all buffers by 50 mM Tris-HCl to 401 
avoid phosphate binding. Solubilized protein was bound to a 1mL Histrap column 402 
(GE Healthcare) and washed with buffer containing 75ௗmM imidazole and 0.05% 403 
(w/v) ȕ-DDM. Purified protein was eluted with 500ௗmM imidazole and exchanged into 404 
a final buffer of 50ௗmM sodium phosphate for XylE and LacY, or 50mM Tris-HCl for 405 
GlpT, 100ௗmM NaCl, 10% (v/v) glycerol, 1ௗmM B-mercaptoethanol, 0.02% ȕ-DDM pH 406 
7.4 by gel filtration chromatography. The samples were either flash-frozen and kept 407 
at -80C until use or concentrated on Amicon 50K concentrators and used directly for 408 
HDX-MS experiments. It is worth noting that the mutant GlpT E153Q was designed 409 
based on sequence conservation but was not kept for further analysis because of the 410 
poor stability and aggregation. 411 
MSP1E3D1 production and purification 412 
Membrane scaffold protein (MSP1D1E3) was expressed and purified as 413 
previously described 19, with the following modifications. Briefly, E. coli BL21(DE3) 414 
(New England Biolabs) cells containing the MSP1D1E3 gene in pET-28a(+) were 415 
plated on LB-agar plates supplemented with kanamycin (30 ȝg mLí1). A single 416 
colony was used to inoculate 30 mL of LB supplemented with 30 ȝg mLí1 of 417 
kanamycin. A dense overnight culture of 30 mL was used to inoculate a secondary 418 
culture in 1 L Terrific broth supplemented with 30 ȝg mLí1 kanamycin. Cultures were 419 
grown at 37 °C with shaking to an OD600 of ~2.2–2.5, and then expression of 420 
MSP1D1E3 was induced by addition of 1 mM IPTG. Cultures were further grown for 421 
4 h at 37 °C, and cells were harvested by centrifugation. Cell pellets were 422 
resuspended in 30 mL of lysis buffer (20 mM sodium phosphate, 1% Triton X-100, 423 
pH 7.4), including one-third of a Complete EDTA-free protease-inhibitor-cocktail 424 
tablet (Pierce), 10 ȝg mLí1 Benzonase I, and were lysed by 2 passes at 15,000 psi in 425 
a high-pressure homogenizer. The lysate was centrifuged at 30,000g for 30 min, and 426 
the supernatant was mixed with 3 mL of Ni–NTA resin equilibrated with lysis buffer. 427 
The slurry was transferred to a column, and the flow-through was discarded. The 428 
resin was washed with four bed volumes of buffer A (40 mM Tris-HCl and 0.3 M 429 
NaCl, pH 8.0) containing 1% Triton X-100, four bed volumes of buffer A containing 430 
50 mM sodium cholate, four bed volumes of buffer A containing 20 mM imidazole 431 
and four bed volumes of buffer A containing 50 mM imidazole. The bound protein 432 
was eluted stepwise with buffer A containing 300 mM imidazole. The eluted 433 
MSP1D1E3 was passed over a desalting column into MSP buffer (50 mM Tris-HCl, 434 
0.1 M NaCl and 0.5 mM EDTA, pH 7.5), and the concentration was determined on 435 
the basis of the absorbance at 280 nm (extinction coefficient = 29,910 Mí1 cmí1). 436 
The protein was concentrated to ~15 mg mLí1 on a 10 K MWCO concentrator 437 
(Amicon). The purity was assessed by SDS–PAGE and Coomassie staining. The 6-438 
his tag was removed by overnight incubation at 4C with TEV protease (80ug of TEV 439 
to cleave 1mg of MSP). The non his-tagged MSP were collected by reverse IMAC, 440 
and concentrated again to ~15 mg mLí1 441 
Lipid preparation for nanodiscs 442 
Lipids DOPE, DOPE(Me)1, DOPC, DOPG, 18:1 CL dissolved in chloroform 443 
(Avanti Polar Lipids) were combined in a 7:2:1 ratio to reach a final quantity of 100 444 
mg, dried under nitrogen flow and then desiccated overnight under vacuum. The lipid 445 
films were hydrated with MSP buffer to reach a final concentration of 40 mg mLí1. ȕ-446 
DDM was added to the mixture to a final concentration of 7.5% (w/v). The lipids were 447 
further homogenized by 4 cycles of freeze-thawing, divided into 100µL aliquots and 448 
stored at í80 °C. The choice of the chain length was motivated by the low Tm 449 
temperature of dioleoyl chains, which facilitates the reconstitution of the membrane 450 
proteins at 4 °C. 451 
Reconstitution of MFS transporters into nanodiscs  452 
For reconstitution into nanodiscs, XylE WT or mutants in ȕ-DDM micelles 453 
were mixed with the appropriate DOPE or DOPC-based lipid mixture, MSP1D1E3 454 
and ȕ-DDM in the following molar ratios: lipid/MSP1D1E3, 60:1; MSP1D1E3/XylE, 455 
8:1; and ȕ-DDM/lipid, 3:1. Samples were rocked at room temperature for 30 min then 456 
incubated overnight at 4 °C with rocking. Biobeads SM-2 (700 mg mLí1) (Bio-Rad) 457 
were added to the mixture and incubated for 2 h at 4 °C, then 1h at RT. The removal 458 
of the Biobeads was achieved by low-speed centrifugation of the nanodisc assembly 459 
in tubes that had been perforated with a needle to form a tiny hole. Full nanodiscs 460 
were separated from empty ones on Ni-NTA high affinity beads (500µL of beads for 461 
1 mg of reconstituted XylE), eluted with nanodiscs purification buffer (sodium 462 
phosphate 50 mM, 100 mM NaCl, 10% glycerol) supplemented with 300mM 463 
imidazole. The full discs were further purified by size-exclusion chromatography on a 464 
Superdex200 column (GE) using nanodiscs purification buffer, then were 465 
concentrated to 100 µL final volume with Amicon Ultra-50K centrifugal filter units at a 466 
speed not exceeding 2,000g. Full nanodiscs were then characterized with SDS–467 
PAGE to assess reconstitution and DLS to ensure homogenous size of the 468 
nanodiscs. All DLS measurements were carried out on a Zetasizer Nano ZS 469 
(Malvern). 470 
Hydrogen deuterium exchange mass spectrometry  471 
Hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments 472 
were performed on a Synapt G2Si HDMS coupled to an Acquity UPLC M-Class 473 
system with HDX and automation (Waters Corporation, Manchester UK). Membrane 474 
proteins samples in detergent micelles (see next section for nanodiscs samples) 475 
were prepared at a concentration of 25 to 70 ȝM using Vivaspin concentrators with a 476 
50,000 MWCO cutoff. Isotope labelling was initiated by diluting 5 ȝl of each protein 477 
sample into 95 ȝL of buffer L (10 mM potassium phosphate in D2O pD 6.6). The 478 
protein was incubated for 30 s, 5 min and 30 min to capture short, medium and long 479 
exchange times and then quenched in ice cold buffer Q (100 mM potassium 480 
phosphate, brought to pH 2.3 with formic acid) before being digested online with a 481 
Waters Enzymate BEH pepsin column at 20 °C. The same procedure was used for 482 
undeuterated controls, with the labelling buffer being replaced by buffer E (10 mM 483 
potassium phosphate in H2O pH 7.0). The peptides were trapped on a Waters BEH 484 
C18 VanGuard pre-column for 3 minutes at a flow rate of 200 ȝL / min in buffer A 485 
(0.1 % formic acid ~ pH 2.5) before being applied to a Waters BEH C-18 analytical 486 
column. Peptides were eluted with a linear gradient of buffer B (8-40% gradient of 487 
0.1 % formic acid in acetonitrile) at a flowrate of 40 ȝL / min. All trapping and 488 
chromatography was performed at 0.5 °C to minimize back exchange. The 489 
electrospray ionization source was operated in the positive ion mode and ion mobility 490 
was enabled for the instrument. MSE data were acquired with a 20 to 30 V trap 491 
collision energy ramp for high-energy acquisition of product ions. Leucine Enkephalin 492 
(LeuEnk - Sigma) was used as a lock mass for mass accuracy correction and the 493 
mass spectrometry was calibrated with sodium iodide. The on-line Enzymate pepsin 494 
column was washed with pepsin wash (1.5 M Gu-HCl, 4 % MeOH, 0.8 % formic 495 
acid) recommended by the manufacturer and a blank run using the pepsin wash was 496 
performed between each sample to prevent significant peptide carry-over from the 497 
pepsin column. Optimized peptide identification and peptide coverage for all samples 498 
was performed from undeuterated controls (five replicates). All deuterium time points 499 
were performed in triplicate.  500 
Data evaluation and statistical analysis 501 
Sequence identification was made from MSE data from the undeuterated 502 
samples using ProteinLynx Global Server 2.5.1 (PLGS Waters Corp. Manchester 503 
UK). The output peptides were filtered using DynamX (v. 3.0) using the following 504 
filtering parameters: minimum intensity of 1000, minimum and maximum peptide 505 
sequence length of 5 and 25 respectively, minimum MS/MS products of 2, minimum 506 
products per amino acid of 0.25, minimum score of 5, and a maximum MH+ error 507 
threshold of 15 ppm. Additionally, all the spectra were visually examined and only 508 
those with high signal to noise ratios were used for HDX-MS analysis. The amount of 509 
relative deuterium uptake for each peptide was determined using DynamX (v. 3.0) 510 
and are not corrected for back exchange since only relative differences were used 511 
for analysis and interpretation and there was no benefit from normalizing the data60. 512 
The relative fractional uptake (RFU) was calculated from RFUa = [Ya,t/(MaxUptakea x 513 
D)], where Y is the deuterium uptake for peptide a at incubation time t, and D is the 514 
percentage of deuterium in the present in the sample after mixing the protein with the 515 
labeling solution. Confidence intervals for the summed ǻHDX over the three time 516 
points were then determined according to Houde et al61. Specifically, the significance 517 
of the summed difference was assessed by a t-test (n = 3; P  0.01, two-sided, 518 
unpaired) to evaluate the overall difference in uptake. All the peptides passing the 519 
test were mapped on the 3D structure and topological map of the protein of interest, 520 
using an in-house script which follows a binary color scheme in which any positive 521 
∆HDX (variable minus control) is red and any negative ∆HDX is blue. The code is 522 
available on GitHub code repository (https://github.com/andymlau/Deuteros).  523 
Preparation of nanodiscs samples for HDX-MS 524 
We found that the nanodisc concentration was a critical parameter to obtain a 525 
good sequence coverage and the HDX conditions were manually optimized for each 526 
nanodiscs sample. Practically, the purified and concentrated nanodiscs were tested 527 
for coverage by performing a reference only run on the mass spectrometer and the 528 
coverage was immediately assed using PLGS. The protein was concentrated using 529 
mini vivaspin concentrators (Amicon, cut-off 50K MWCO) until a coverage of more 530 
than 85% was achieved. Then, the optimal sample scheme for HDX purposes was 531 
as follows: 5 ȝL of nanodiscs sample was diluted into 95 ȝL of nanodiscs purification 532 
buffer or with deuterated buffer nanodiscs purification buffer at 22 °C. The 533 
deuterated samples were left for 5 min, 30 min and 150 min at 22 °C in a dry bath. 534 
All samples were then quenched with 100 ȝL of quench buffer (100 mM potassium 535 
phosphate, brought to pH 2.4 with formic acid, 0.2% DDM) The sample was vortexed 536 
for 3 s then placed immediately on ice for 1 minute. 10 ȝl of ZrO2 beads (300 mg/mL 537 
equilibrated in quench buffer) was then added to remove lipids and the sample 538 
vortexed for 3 s, placed on ice for 30 s, vortexed for a further 3 s, and then placed on 539 
ice for a further 30 s. The samples were then filtered through pre-chilled 0.22 ȝm 540 
spin filtration devices (Corning Costar Spin-X) in a pre-chilled microcentrifuge at 541 
1,000 x g for 30 s. Digested or undigested samples were then immediately flash 542 
frozen in liquid nitrogen and stored at -80 °C before analysis. Samples were rapidly 543 
defrosted and then injected into a Waters HDX nanoAcquity ultra-performance liquid 544 
chromatography (UPLC) system (Waters) using a pre-chilled syringe, as described in 545 
the previous section.  546 
Molecular Dynamics (MD) simulations set-up 547 
All the simulations were initiated from the IF-open state of XylE (PDB 548 
ID:4JA4)10. Missing loops and helices were modelled using superlooper62 using the 549 
OF-open state of XylE (4GBY as the template). Assignment of the protonation state 550 
was done on the basis of pKa calculations performed using PROPKA 3.1 at pH763. 551 
Accordingly, all the glutamate and aspartate except D27 were modelled in their 552 
default (unprotonated) form. Using the membrane replacement method in CHARMM-553 
GUI64, XyLE was embedded in lipid bilayers of two compositions (DOPE-DOPG-CL 554 
(70:20:10) and DOPC-DOPG-CL (70:20:10)), closely mimicking the experimental 555 
conditions. System was solvated with TIP3P water molecules65. Thereafter, Na+ and 556 
Cl− ions were added and the system was neutralized with the ionic concentration set 557 
to 100 mM. The final system inclusive of the protein, lipids, water molecules and ions 558 
comprised of ~ 105 K atoms. Thereafter, the system was minimized for 5,000 steps 559 
using conjugate gradient algorithm and simulated for 5 ns at 310 K, with all the 560 
heavy atoms of the protein restrained to their crystallographic positions with a force 561 
constant of k = 5 kcal/mol/Å2. In the next step, the system was further simulated for 5 562 
ns with harmonic restraints (k = 5 kcal/mol/Å2) applied only to the parts of the protein 563 
that was modelled using superlooper. Finally, all the restrains were removed and the 564 
systems were simulated for 500 ns. 565 
MD simulation protocol 566 
The simulations were performed on with NAMD 2.1266 utilizing CHARMM36 567 
all-atom forcefields for proteins and lipids67. NPT ensemble with periodic boundary 568 
conditions was used for all simulations. Simulations were performed at 310 K using 569 
Langevin dynamics68 with a damping constant of 0.5 ps-1. Pressure was maintained 570 
at 1 atm using the Nosé-Hoover Langevin piston method68. The cutoff used for the 571 
short-range interactions were 12 Å with the switching applied at 10 Å. We used 572 
particle mesh Ewald (PME) algorithm to calculate the long-range electrostatic 573 
forces69. Bonded, non-bonded, and PME calculations were performed at 2-, 2-, and 574 
4-fs intervals, respectively.  575 
Data availability 576 
Data supporting the findings of this manuscript are available from the 577 
corresponding author upon reasonable request. All the deuterium uptake plots and 578 
uptake datasets of the experiments presented in this work are available on figshare 579 
data repository. XylE data can be accessed using the following DOI 580 
10.6084/m9.figshare.7072988. LacY data can be accessed using the following DOI 581 
10.6084/m9.figshare.7073072. GlpT data can be accessed using the following DOI 582 
10.6084/m9.figshare.7073003. Furthermore, the mass spectrometry proteomics data 583 
have been deposited to the ProteomeXchange Consortium via the PRIDE70 partner 584 
repository with the dataset identifier PXD011060.  585 
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Figure Legends 769 
 770 
Figure 1 HDX-MS reports on changes in the conformational equilibrium between IF and OF states  771 
G to W mutants were used to highlight shifts in the conformational equilibrium. (a) Introduction of a tryptophan at 772 
the extracellular end of helix 2 sterically prevents closing. After deuteration, enzymatic digestion, and 773 
identification of the peptides by MS the mass uptake of the WT and mutants is compared. Peptides located on 774 
the intracellular side will be on average more deuterated than the peptides located on the extracellular side for 775 
the mutant (top graph) while the opposite pattern will be observed for the WT (bottom graph). (b) Differential 776 
deuterium uptake pattern (∆HDX) mapped onto the 3D and topological structure of LacY (PDB: 2V8N), GlpT 777 
(PDB: 1PW4) and XylE (PDB: 4GBY). Red and blue colored regions indicate segments containing peptides with 778 
a positive ∆HDX (red – more deuteration) or negative ∆HDX (blue – less deuteration), respectively; white regions 779 
indicate that no significant ∆HDX is observed (p ≤ 0.01), and grey indicates regions where peptides were not 780 
obtained for both the mutant and the WT conditions. The yellow star indicates the location of the point mutation. 781 
All measurements were performed in triplicates. The ∆HDX datasets are presented as Woods plots in 782 
supplementary Figs.12 and 13. 783 
 784 
Figure 2 Conserved charge-relay networks control intracellular opening  785 
Disruption of the networks by conservative mutations (D to N and E to Q) shifts the conformational equilibrium 786 
towards the IF state. (a) Two charge-relay networks of conserved residues stabilize the OF state of XylE. The N 787 
and C- lobes are colored blue and tan respectively. Close-up of networks 1 and 2 - highlighted in green and 788 
purple respectively - show the connection between the two lobes and highlight in red the mutated acidic residues. 789 
(b) ∆HDX between the mutants E153Q, E397Q and D337N vs WT mapped onto the 3D and topological structure 790 
of XylE. (c) ∆HDX of the mutants D68N, and E139Q vs WT mapped onto the 3D and topological structure of 791 
LacY. (d) ∆HDX of the mutants E374Q and D314N mapped onto the 3D and topological structure of GlpT. All 792 
measurements were performed in triplicates on two biological replicates. The ∆HDX datasets are presented as 793 
Woods plots in supplementary Figs.12 and 13. 794 
 795 
Figure 3 Lipid-protein interactions regulate the conformational equilibrium  796 
∆HDX of XylE WT in PE vs PC nanodiscs shows that PE promotes the IF conformation (a) Optimized 797 
experimental procedure for HDX-MS of a transporter in nanodiscs of different lipid compositions. Following 798 
deuteration at specific time-points, the exchange reaction is quenched and the nanodiscs disassembled with 799 
detergent DDM. Lipids are removed by adsorption, before enzymatic digestion and peptides identification by MS. 800 
The mass uptake of the protein in both lipid environments is then compared. (b) ∆HDX of WT XylE in DOPE-PG-801 
CL nanodiscs (native-like) minus DOPC-PG-CL (control) nanodiscs mapped on the PDB structure and the 802 
topological representation (c) Representative deuterium uptake plots for peptide 28-38, (d) 70-88, (e) 108-122, (f) 803 
430-434 in DOPC-PG-CL nanodiscs (green) and DOPE-PG-CL nanodiscs (black). Standard deviations for each 804 
time point are plotted as error bars (n=3). All measurements were performed in triplicates.  805 
 806 
Figure 4 MD simulations reveal that PE – protein interactions perturb the charge-relay networks  807 
MD simulations predict specific interactions between the PE headgroup and charged residues of networks 1 and 808 
2 in XylE (a) Simulation box. Representative snapshot of XylE (PDB: 4JA4) embedded in an explicit lipid bilayer 809 
and water box with 100 mM NaCl. Lipid molecules are shown in line representation coloured in silver, 810 
phosphorus atom of the head group represented by orange spheres. Yellow and green spheres represent Na+ 811 
and Cl- ions respectively. (b) Representative snapshot of the close-up of network 1 interacting with the PE 812 
headgroup of the phospholipid. Polar interactions with R84 and E153 prevent network formation and steric 813 
hindrance prevents contacts of the TM2 and TM11. (c) Location of the phosphorus atoms of the PE/PC lipid 814 
molecule in two 500 ns trajectories in PE:PG:CL bilayers (left) and PC:PG:CL bilayers (right). The spheres are 815 
colour coded: red at t=0 ns and blue at t = 500 ns. In both simulations 1 and 2, PE lipids wedge between the 816 
helices (more so in simulation 1), but no lipid-protein interaction is observed in PC bilayers. In simulation 1, direct 817 
interactions with residues R84, E153 and R404 of network 1 are observed.  818 
 819 
Figure 5 Closing of the intracellular side of XylE in PC:PG:CL bilayers  820 
MD simulations predict different conformational changes of XylE in PC vs PE bilayers (a) Representative 821 
snapshots at the beginning (t=0 ns) and end of the simulation (t=500 ns) show a closing of the intracellular side in 822 
PC nanodisc (left) compared to PE nanodisc (right). (b) Time trace showing the intracellular gate distance over 823 
simulation time. PC simulation sets are coloured orange and red, while the PE simulation sets are coloured green 824 
and blue. The inset on the right depicts the normalized distribution of the intracellular gate distance for the last 825 
200 ns of the trajectory. (c) Snapshot describing the definition of the intracellular gates in XylE. The intracellular 826 
gating distance is defined as the centre of mass (COM) distance between the two groups of Ca-Ca residues: 827 
group1 residues (75-80 149-154 160-16) and group2 residues (332-337 391-397 404-410). 828 
 829 
Figure 6 Disruption of conserved charge networks abolishes or decreases lipid-induced conformational 830 
shift  831 
∆HDX of XylE in PE:PG:CL nanodiscs (native-like) minus PC:PG:CL (control) nanodiscs mapped on the PDB 832 
structure and the topological representation of XylE for (a) XylE E153Q and (b) XylE E397Q. All measurements 833 
were performed in triplicates. 834 
 835 
Figure 7 A lipid-mediated mechanism of transport  836 
Model of secondary transport based on the interaction between charge-relay networks of XylE and PE 837 
phospholipid (i) Substrate (orange) binds from the extracellular side and stabilizes the OF conformation. (ii) 838 
Proton binding triggers closure of the extracellular side. (iii) The fully loaded transporter transitions towards an 839 
occluded conformational intermediate. Proton translocates through the transporter to the conserved charge relay 840 
networks (pink) on the intracellular side (iv) Disruption of the charge networks opens the intracellular side. 841 
Spontaneous deprotonation upon exposure to the slightly basic cytosol leads to intracellular proton release. (v) 842 
Direct interactions between PE and the transporter stabilize the inward-facing conformation, thus facilitating 843 
substrate release and completing the transport cycle. Reformation of the cytoplasmic charge relay networks 844 
leads to the subsequent conformational switch. (vi) is equivalent to (i).  845 
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